Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-06-12 Purchase | 2023-06-12 6:17 pm | Akoya Biosciences Inc. | AKYA | Mendel Scott Director | 20,000 | $5 | $100,000 | 28,500 (Direct) | View |
| 2021-11-19 Purchase | 2021-11-19 12:55 pm | Akoya Biosciences Inc. | AKYA | Mendel Scott Director | 8,500 | $13.16 | $111,860 | 8,500 (Direct) | View |
| 2021-01-25 Sale | 2021-01-25 8:35 pm | GenMark Diagnostics Inc. | GNMK | Mendel Scott President & CEO | 64,975 | $14.23 | $924,594 | 593,519 (Indirect Direct) | View |
| 2021-01-19 Sale | 2021-01-21 8:09 pm | GenMark Diagnostics Inc. | GNMK | Mendel Scott President & CEO | 50,000 | $14.54 | $727,000 | 1,119,490 (Indirect Direct) | View |
| 2020-11-24 Sale | 2020-11-25 5:29 pm | GenMark Diagnostics Inc. | GNMK | Mendel Scott President & CEO | 5,190 | $13.17 | $68,352 | 562,321 (Indirect Direct) | View |
| 2020-11-19 Sale | 2020-11-20 6:09 pm | GenMark Diagnostics Inc. | GNMK | Mendel Scott President & CEO | 3,987 | $13.85 | $55,220 | 567,511 (Indirect Direct) | View |
| 2020-08-26 Sale | 2020-08-28 5:53 pm | GenMark Diagnostics Inc. | GNMK | Mendel Scott President & CEO | 50,000 | $15.02 | $751,000 | 571,498 (Indirect Direct) | View |
| 2020-08-25 Sale | 2020-08-26 6:30 pm | GenMark Diagnostics Inc. | GNMK | Mendel Scott President & CEO | 4,532 | $14.14 | $64,082 | 621,498 (Indirect Direct) | View |
| 2020-08-20 Sale | 2020-08-24 6:13 pm | GenMark Diagnostics Inc. | GNMK | Mendel Scott President & CEO | 2,988 | $15.41 | $46,045 | 626,030 (Indirect Direct) | View |
| 2020-08-12 Sale | 2020-08-14 6:06 pm | GenMark Diagnostics Inc. | GNMK | Mendel Scott President & CEO | 50,000 | $15.08 | $754,000 | 629,018 (Indirect Direct) | View |
| 2020-05-28 Sale | 2020-06-01 5:08 pm | GenMark Diagnostics Inc. | GNMK | Mendel Scott President & CEO | 3,751 | $9.52 | $35,710 | 629,018 (Indirect Direct) | View |
| 2020-05-19 Sale | 2020-05-20 6:02 pm | GenMark Diagnostics Inc. | GNMK | Mendel Scott President & CEO | 2,800 | $10.46 | $29,288 | 632,769 (Indirect Direct) | View |
| 2020-02-27 Sale | 2020-02-28 5:50 pm | GenMark Diagnostics Inc. | GNMK | Mendel Scott Interim President & CEO | 2,659 | $3.51 | $9,333 | 635,569 (Indirect Direct) | View |
| 2020-02-25 Sale | 2020-02-27 8:54 pm | GenMark Diagnostics Inc. | GNMK | Mendel Scott Interim President & CEO | 1,402 | $3.81 | $5,342 | 713,228 (Indirect Direct) | View |
| 2020-02-20 Sale | 2020-02-21 5:17 pm | GenMark Diagnostics Inc. | GNMK | Mendel Scott Interim President & CEO | 14,536 | $3.8 | $55,237 | 414,630 (Indirect Direct) | View |
| 2020-01-23 Sale | 2020-01-23 6:34 pm | GenMark Diagnostics Inc. | GNMK | Mendel Scott Chief Operating Officer | 7,652 | $4.92 | $37,648 | 476,172 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-10-02 Option Award | 2024-10-04 6:44 pm | N/A 2034-10-02 | Akoya Biosciences Inc. | AKYA | Mendel Scott Director | 44,959 | $0 | 44,959 (Direct) | View |
| 2024-06-04 Option Award | 2024-06-05 5:53 pm | N/A 2034-06-04 | Akoya Biosciences Inc. | AKYA | Mendel Scott Director | 50,000 | $0 | 50,000 (Direct) | View |
| 2024-05-16 Option Award | 2024-05-17 4:47 pm | N/A 2034-05-16 | Quantum-Si Inc | QSI | Mendel Scott Director | 113,281 | $0 | 113,281 (Direct) | View |
| 2023-06-01 Option Award | 2023-06-05 5:38 pm | N/A 2033-06-01 | Akoya Biosciences Inc. | AKYA | Mendel Scott Director | 56,322 | $0 | 56,322 (Direct) | View |
| 2023-05-12 Option Award | 2023-05-16 4:53 pm | N/A N/A | Quantum-Si Inc | QSI | Mendel Scott Director | 141,843 | $0 | 141,843 (Direct) | View |
| 2022-06-01 Option Award | 2022-06-03 4:03 pm | N/A 2032-06-01 | Akoya Biosciences Inc. | AKYA | Mendel Scott Director | 30,549 | $0 | 39,049 (Direct) | View |
| 2021-06-11 Option Award | 2021-06-15 9:59 pm | N/A 2031-06-11 | Akoya Biosciences Inc. | AKYA | Mendel Scott Director | 35,562 | $0 | 35,562 (Direct) | View |
Ownership | 2021-06-15 9:58 pm | N/A N/A | Akoya Biosciences Inc. | AKYA | Mendel Scott Director | 0 | $0 | 0 (Direct) | View |
| 2021-04-22 Equity Swap | 2021-04-22 1:49 pm | N/A N/A | GenMark Diagnostics Inc. | GNMK | Mendel Scott President & CEO | 622,689 | $24.05 | 0 (Direct) | View |
| 2021-04-22 Disposition | 2021-04-22 1:49 pm | N/A N/A | GenMark Diagnostics Inc. | GNMK | Mendel Scott President & CEO | 301,268 | $0 | 0 (Direct) | View |
| 2021-02-25 Tax Withholding | 2021-03-01 5:53 pm | N/A N/A | GenMark Diagnostics Inc. | GNMK | Mendel Scott President & CEO | 41,834 | $0 | 622,689 (Direct) | View |
| 2021-02-23 Tax Withholding | 2021-02-25 6:33 pm | N/A N/A | GenMark Diagnostics Inc. | GNMK | Mendel Scott President & CEO | 3,254 | $0 | 664,523 (Direct) | View |
| 2021-02-22 Tax Withholding | 2021-02-24 6:05 pm | N/A N/A | GenMark Diagnostics Inc. | GNMK | Mendel Scott President & CEO | 1,860 | $0 | 667,777 (Direct) | View |
| 2021-02-18 Option Award | 2021-02-22 6:59 pm | N/A N/A | GenMark Diagnostics Inc. | GNMK | Mendel Scott President & CEO | 106,761 | $0 | 696,328 (Direct) | View |
| 2021-02-18 Tax Withholding | 2021-02-22 6:59 pm | N/A N/A | GenMark Diagnostics Inc. | GNMK | Mendel Scott President & CEO | 3,952 | $0 | 696,328 (Direct) | View |
| 2021-01-21 Exercise | 2021-01-21 8:09 pm | N/A N/A | GenMark Diagnostics Inc. | GNMK | Mendel Scott President & CEO | 146,172 | $0 | 1,119,490 (Direct) | View |
| 2020-05-29 Option Award | 2020-06-02 5:56 pm | N/A N/A | GenMark Diagnostics Inc. | GNMK | Mendel Scott President & CEO | 50,000 | $0 | 679,018 (Direct) | View |
| 2020-02-25 Option Award | 2020-02-27 8:54 pm | N/A N/A | GenMark Diagnostics Inc. | GNMK | Mendel Scott Interim President & CEO | 187,500 | $0 | 713,228 (Direct) | View |
| 2020-01-23 Exercise | 2020-01-23 6:34 pm | N/A N/A | GenMark Diagnostics Inc. | GNMK | Mendel Scott Chief Operating Officer | 35,394 | $0 | 476,172 (Direct) | View |